MedPath

Impact of Oncogeriatric Consultation on Quality of Life of Patients Aged 75 and More With Cancer

Conditions
Cancer
Interventions
Other: Data collection
Registration Number
NCT05163015
Lead Sponsor
Université de Reims Champagne-Ardenne
Brief Summary

Among patients with cancer, 6 in 10 are over 65 years of age. In order to improve quality of life of aged cancer patients, the oncogeriatric consultation has been created. Oncogeriatric consultation aim to help oncologists determine the best solutions to combine therapy and quality of life. Factors influencing quality of life of cancer patients have been studied previously. However, these studies always focus on one specific cancer.

Detailed Description

The aim of the study is to study factors associated with quality of life in patients aged 75 and more with cancer, notably the oncogeriatric consultation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • male or female
  • aged of 75 and more
  • with cancer
  • with indication of oncogeriatric consultation according G8
  • agreeing to participate in the study
Exclusion Criteria

-less than 75 years old

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
with oncogeriatric consultationData collectionwith oncogeriatric consultation" group: patients aged 75 and more with cancer with oncogeriatric consultation
without oncogeriatric consultationData collectionwithout oncogeriatric consultation" group: patients aged 75 and more with cancer without oncogeriatric consultation
Primary Outcome Measures
NameTimeMethod
EORTC QLQ-C30Day 60

The QLQ-C30 is a generic questionnaire with 30 questions coded in 4 response modalities (not at all (1), a little (2), enough (3), a lot (4)) or in 7 response modalities (from very bad (1) to excellent ( 7)).

Questions are summarized in five multiitem domains (physical, role, cognitive, emotional, and social functioning) and nine single item domains (fatigue, pain, nausea/vomiting, appetite loss, financial impact; diarrhea, constipation, sleep disturbance and quality of life).

Each domain is scored between 0 and 100. For functional domains, a high score value represents a high level of quality of life. For symptom domains, a high score represents an important level of symptoms (a low level of quality of life).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut Godinot

🇫🇷

Reims, Grand-Est, France

© Copyright 2025. All Rights Reserved by MedPath